In a National Institute on Aging-supported study released this week, Alzheimer's researchers found that levels of the protein apolipoprotein E in blood samples were strongly associated with levels of beta-amyloid deposits in the brain.

Because increased deposits of beta-amyloid are considered a hallmark of Alzheimer's, this link suggests that ApoE could be used as a blood-based protein biomarker for the disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.